Výsledky vyhledávání - "Renate Klauser-Braun"

Akademický článek

Atrial fibrillation and anticoagulation are associated with hospitalisations in patients with end-stage kidney disease on haemodialysis: a prospective population-based cohort study

Autor: Daniel Steiner, Sabine Schmaldienst, Matthias Lorenz, Renate Klauser-Braun, Ingrid Pabinger, Cihan Ay, Marcus Säemann, Oliver Königsbrügge

Publikováno v: Thrombosis Journal, Vol 20, Iss 1, Pp 1-10 (2022)

Abstract Background Patients with end-stage kidney disease on haemodialysis suffer from frequent complications requiring hospitalisation. Atrial fibrillation is a burdensome comorbidity amongst patients on haemodialysis. We aimed to assess frequency,

Externí odkaz: https://doaj.org/article/56a1ae851382422e8ae5c2fe7a2ba1e7

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Blood volume-monitored regulation of ultrafiltration to decrease the dry weight in fluid-overloaded hemodialysis patients: a randomized controlled trial

Autor: Marlies Antlanger, Peter Josten, Michael Kammer, Isabella Exner, Katharina Lorenz-Turnheim, Manfred Eigner, Gernot Paul, Renate Klauser-Braun, Gere Sunder-Plassmann, Marcus D. Säemann, Manfred Hecking

Publikováno v: BMC Nephrology, Vol 18, Iss 1, Pp 1-11 (2017)

Abstract Background Because chronic fluid volume overload is associated with higher mortality, we tested whether blood-volume monitored regulation of ultrafiltration and dialysate conductivity (UCR) and/or regulation of ultrafiltration and temperatur

Externí odkaz: https://doaj.org/article/7dfe53f46de545c09c4f04a1dc7c5b45

Zobrazit plný text záznamu

Akademický článek

Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).

Autor: Oliver Königsbrügge, Florian Posch, Marlies Antlanger, Josef Kovarik, Renate Klauser-Braun, Josef Kletzmayr, Sabine Schmaldienst, Martin Auinger, Günther Zuntner, Matthias Lorenz, Ella Grilz, Gerald Stampfel, Stefan Steiner, Ingrid Pabinger, Marcus Säemann, Cihan Ay

Publikováno v: PLoS ONE, Vol 12, Iss 1, p e0169400 (2017)

Atrial fibrillation (AF) adds significant risk of stroke and thromboembolism in patients on hemodialysis (HD). The aim of this study was to investigate the prevalence of AF in a population-based cohort of HD patients and practice patterns of antithro

Externí odkaz: https://doaj.org/article/2eb0db03bbec45d2bc620d4fe06c6920

Zobrazit plný text záznamu

Individualising antihypertensive therapy in patients with diabetes. A guideline by the Austrian Diabetes Association (update 2023)

Autor: Christoph H. Saely, Gerit-Holger Schernthaner, Johanna Brix, Renate Klauser-Braun, Emanuel Zitt, Heinz Drexel, Guntram Schernthaner

Publikováno v: Wiener klinische Wochenschrift. 135:147-156

ZusammenfassungHypertonie ist eine sehr häufige Komorbidität bei Patient:innen mit Diabetes mellitus, die – wenn unzureichend behandelt – signifikant zur erhöhten Mortalität und zum Auftreten von mikrovaskulären und makrovaskulären Komplika

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bf4d0509c0ce0c764e211213f22ad9e6
https://doi.org/10.1007/s00508-023-02189-1

Zobrazit plný text záznamu

Growth differentiation factor-15 (GDF-15) predicts major bleeding, major adverse cardiac events, and mortality in patients with end-stage kidney disease on hemodialysis: findings from the VIVALDI study

Autor: Stephan, Nopp, Oliver, Königsbrügge, Sabine, Schmaldienst, Renate, Klauser-Braun, Matthias, Lorenz, Ingrid, Pabinger, Marcus, Säemann, Cihan, Ay

Publikováno v: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Patients with end-stage kidney disease (ESKD) are at high risk of cardiovascular events and bleeding. Optimizing risk assessment of ESKD patients regarding risk of thromboembolism and bleeding complications in comorbid conditions, including atrial fi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::442f1dc66e78364cc6ccc2d8f14e5639
https://pubmed.ncbi.nlm.nih.gov/36472548

Zobrazit plný text záznamu

Growth differentiation factor-15 predicts major bleeding, major adverse cardiac events and mortality in patients with end-stage kidney disease on haemodialysis: findings from the VIVALDI study

Autor: Stephan Nopp, Oliver Königsbrügge, Sabine Schmaldienst, Renate Klauser-Braun, Matthias Lorenz, Ingrid Pabinger, Marcus Säemann, Cihan Ay

Publikováno v: Nephrology Dialysis Transplantation.

BackgroundPatients with end-stage kidney disease (ESKD) are at high risk of cardiovascular events and bleeding. Optimizing risk assessment of ESKD patients regarding the risk of thromboembolism and bleeding complications in comorbid conditions, inclu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::254e4889b2fa25e845253d2292b969aa
https://doi.org/10.1093/ndt/gfac321

Zobrazit plný text záznamu

Antithrombotic agents for primary and secondary prevention of cardiovascular events in patients with end-stage renal disease on chronic hemodialysis

Autor: Oliver Königsbrügge, Manfred Hecking, Marcus D. Säemann, Martin Auinger, Renate Klauser-Braun, Matthias Lorenz, Sabine Schmaldienst, Jolanta M. Siller-Matula, Brigitte Enzenberger, Cihan Ay, Ingrid Pabinger, Susanne Tabernig, Manfred Eigner, Josef Kletzmayr

Publikováno v: Atherosclerosis. 298:1-6

Background and aims Cardiovascular disease (CVD) is common in patients with end-stage renal disease (ESRD) on hemodialysis (HD). However, antithrombotic therapy to prevent CVD increases the risk of bleeding. We aimed to investigate the prevalence of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ff78ff01188954492acba2ff79a8df6
https://doi.org/10.1016/j.atherosclerosis.2020.02.011

Zobrazit plný text záznamu

Bleeding Risk Assessment in End-Stage Kidney Disease: Validation of Existing Risk Scores and Evaluation of a Machine Learning-Based Approach

Autor: Stephan Nopp, Clemens P. Spielvogel, Sabine Schmaldienst, Renate Klauser-Braun, Matthias Lorenz, Benedikt N. Bauer, Ingrid Pabinger, Marcus Säemann, Oliver Königsbrügge, Cihan Ay

Publikováno v: Thrombosis and haemostasis. 122(9)

Background Patients with end-stage kidney disease (ESKD) on hemodialysis (HD) are at increased risk for bleeding. However, despite relevant clinical implications regarding dialysis modalities or anticoagulation, no bleeding risk assessment strategy h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0320df4e099ad616fccf89f37d1bff32
https://pubmed.ncbi.nlm.nih.gov/35098518

Zobrazit plný text záznamu

Anticoagulation use and the risk of stroke and major bleeding in patients on hemodialysis: From the VIVALDI, a population-based prospective cohort study

Autor: Josef Kletzmayr, Oliver Königsbrügge, Martin Auinger, Renate Klauser-Braun, Aljoscha Beyer, Hannah Meisel, Matthias Lorenz, Irene Lang, Ingrid Pabinger, Sabine Schmaldienst, Manfred Hecking, Marcus D. Säemann, Cihan Ay, Wolfgang C. Winkelmayer

Publikováno v: Journal of thrombosis and haemostasis : JTHREFERENCES. 19(12)

Background Evidence supporting the use of anticoagulation for the prevention of stroke and thromboembolism in patients with kidney failure on hemodialysis (HD) and atrial fibrillation (AF) is limited. We prospectively assessed the incidences of strok

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50aefdfd47f23444d2651d4f93b338b6
https://pubmed.ncbi.nlm.nih.gov/34418291

Zobrazit plný text záznamu

Management of secondary hyperparathyroidism: practice patterns and outcomes of cinacalcet treatment with or without active vitamin D in Austria and Switzerland – the observational TRANSIT Study

Autor: Gunther Pendl, Wolfgang Pronai, Andreas Bock, Karl Lhotta, Alexander R. Rosenkranz, Christine Jäger, Renate Klauser-Braun, Margit Hemetsberger

Publikováno v: Wiener Klinische Wochenschrift

Summary Secondary hyperparathyroidism is a complex disorder requiring an individualized multicomponent treatment approach. This study was conducted to identify treatment combinations used in clinical practice in Austria and Switzerland and the potent

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93e1c401114f2cf452695748191832c7
https://doi.org/10.1007/s00508-016-1153-z

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání